-
Simple Pharma acquires Testavan® and Vitaros®, two established men’s health brands, from Ferring
inBy divesting its rights to Simple Pharma on this transaction, Ferring is able to focus on areas of high unmet need to bring the most value to patients and healthcare professionals. Testavan® (transdermal testosterone gel 2%) is a testosterone…
-
Ferring Statement on Minirin® / Octostim®/ DDAVP®/ Stimate® (desmopressin) Nasal Spray
inFollowing the detection of out-of-specification results during testing, in 2020 Ferring initiated a precautionary voluntary global recall of all batches of the following products: Minirin® (desmopressin) Nasal Spray 0.1 mg/ml room…
-
“Standing together against injustice” – a message from Per Falk, President and Chief Science Officer at Ferring
in“Standing together against injustice” – a message from Per Falk, President and…
STATEMENT 2021
STATEMENT 2021